Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Todoerti

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Blood|June 9, 2016
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Martina Chiu, Fabrizio Accardi, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD<sup>+</sup>-Lowering AgentsPamela Becherini, Debora Soncini, Silvia Ravera, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
Haematologica|October 21, 2021
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatmentDebora Soncini, Claudia Martinuzzi, Pamela Becherini, et al.
Blood|February 3, 2023
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axisAntonio Sacco, Vanessa Desantis, Jon Celay, et al.
European Journal of Haematology|March 11, 2015
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Stefano Molica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2025
Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple MyelomaEugenio Morelli, Caroline Fidalgo Ribeiro, Silvia D Rodrigues, et al.
American Journal of Hematology|October 10, 2012
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profilesLaura Mosca, Pellegrino Musto, Katia Todoerti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2013
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemiaMarta Lionetti, Pellegrino Musto, Maria Teresa Di Martino, et al.
Blood Advances|July 12, 2022
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cellsSerena Matis, Anna Grazia Recchia, Monica Colombo, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Blood|June 9, 2016
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Martina Chiu, Fabrizio Accardi, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD<sup>+</sup>-Lowering AgentsPamela Becherini, Debora Soncini, Silvia Ravera, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
Haematologica|October 21, 2021
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatmentDebora Soncini, Claudia Martinuzzi, Pamela Becherini, et al.
Blood|February 3, 2023
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axisAntonio Sacco, Vanessa Desantis, Jon Celay, et al.
European Journal of Haematology|March 11, 2015
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Stefano Molica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2025
Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple MyelomaEugenio Morelli, Caroline Fidalgo Ribeiro, Silvia D Rodrigues, et al.
American Journal of Hematology|October 10, 2012
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profilesLaura Mosca, Pellegrino Musto, Katia Todoerti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2013
Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemiaMarta Lionetti, Pellegrino Musto, Maria Teresa Di Martino, et al.
Blood Advances|July 12, 2022
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cellsSerena Matis, Anna Grazia Recchia, Monica Colombo, et al.
Pageof 11